AI AstraZeneca Signs $5.3 Billion AI-Led Research Deal with CSPCJune 20, 2025 AstraZeneca partners with CSPC Pharmaceutical Group in a deal worth up to $5.3 billion to develop therapies for chronic conditions using AI-driven research
